The Potential of Endogenous Neurogenesis for Brain Repair and Regeneration Following Traumatic Brain Injury
Overview
Authors
Affiliations
Traumatic brain injury (TBI) is the leading cause of death and disability of persons under 45 years old in the United States, affecting over 1.5 million individuals each year. It had been thought that recovery from such injuries is severely limited due to the inability of the adult brain to replace damaged neurons. However, recent studies indicate that the mature mammalian central nervous system (CNS) has the potential to replenish damaged neurons by proliferation and neuronal differentiation of adult neural stem/progenitor cells residing in the neurogenic regions in the brain. Furthermore, increasing evidence indicates that these endogenous stem/progenitor cells may play regenerative and reparative roles in response to CNS injuries or diseases. In support of this notion, heightened levels of cell proliferation and neurogenesis have been observed in response to brain trauma or insults suggesting that the brain has the inherent potential to restore populations of damaged or destroyed neurons. This review will discuss the potential functions of adult neurogenesis and recent development of strategies aiming at harnessing this neurogenic capacity in order to repopulate and repair the injured brain.
Deng T, Ding R, Wang Y, Chen Y, Sun H, Zheng M Front Neurol. 2024; 15:1301277.
PMID: 38523616 PMC: 10957745. DOI: 10.3389/fneur.2024.1301277.
Anaya-Martinez V, Anacleto-Santos J, Mondragon-Flores R, Zepeda-Rodriguez A, Casarrubias-Tabarez B, Lopez-Perez T Microorganisms. 2023; 11(11).
PMID: 38004683 PMC: 10673519. DOI: 10.3390/microorganisms11112671.
Nicotinic acetylcholine receptors and learning and memory deficits in Neuroinflammatory diseases.
Echeverria V, Mendoza C, Iarkov A Front Neurosci. 2023; 17:1179611.
PMID: 37255751 PMC: 10225599. DOI: 10.3389/fnins.2023.1179611.
Gene Therapy Using Efficient Direct Lineage Reprogramming Technology for Neurological Diseases.
Chang Y, Lee S, Kim J, Kim C, Shim H, Lee S Nanomaterials (Basel). 2023; 13(10).
PMID: 37242096 PMC: 10222404. DOI: 10.3390/nano13101680.
Guo X, Ma R, Wang M, Lau B, Chen X, Li Y Front Pharmacol. 2022; 13:971444.
PMID: 36046823 PMC: 9420941. DOI: 10.3389/fphar.2022.971444.